Oruka Therapeutics, Inc. (ORKA) Q1 2024 Earnings
ORKA·Reported April 25, 2024·Before market open
Diluted EPS came in at $-0.14.
Diluted EPS
$-0.14
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Oruka Therapeutics, Inc.'s Q1 2024 earnings report.
Oruka Therapeutics, Inc. (ORKA) reported Q1 2024 earnings on April 25, 2024 before market open.
Oruka Therapeutics, Inc. reported diluted EPS of $-0.14 for Q1 2024.
You can read the 10-Q periodic report (0000950170-24-048329) directly on SEC EDGAR. The filing index links above go to sec.gov.